As a national leader in translational research, the Division of Hematology and Medical Oncology and the OHSU Knight Cancer Institute are well-known for their ability to turn discoveries into cancer treatments.
The OHSU Knight Cancer Institute is involved in more than 400 cancer clinical trials. Studies are focused on new approaches to cancer treatment, cancer prevention, diagnosis and screening and molecular targets for personalized cancer medicine that are tailored to individual tumors.Find out more on clinical trials
Research labsThe Division of Hematology and Medical Oncology research labs are working to turn discoveries into cancer treatments.
Knight Cancer research programsThe Knight Cancer research programs form an interdisciplinary and collaborative infrastructure to enable the full spectrum of translational research to be conducted. Work done by Knight physicians and scientists advance our understanding of the underlying mechanisms of this disease and advance discoveries to improve detection, diagnosis, treatment and prevention of cancer.
Knight Cancer research membership
The research membership of the OHSU Knight Cancer Institute is composed of researchers, scientists and clinicians working together to provide world-class patient care and groundbreaking research to reduce the morbidity and mortality of cancer. Benefits of joining include use of shared resources, priority use of conference facilities, educational opportunities, clinical research support, and more.